GoodRx agrees to $32M settlement. Who's eligible for money?
GoodRx agreed to a $32M settlement to resolve a class-action lawsuit alleging it shared users' health information with third parties. The settlement, pending court approval, covers users who used GoodRx services before April 20, 2024. Claims can be submitted until Dec. 29, with payments depending on the number of approved claims and court processes.
How this was made

The 30-second read
Why it matters
The key tradable element is the $32M settlement and the procedural milestones (claims now, court approval Feb. 11, 2027), which can influence legal-risk pricing and any expectation of additional claims.
Market read
Settlement details and eligibility and claim deadlines can affect investor perception of legal exposure, though the article provides no earnings or guidance impact.
What to watch
Traders may be underweighting the timeline risk: payments depend on court approval and claim participation rates, which can affect perceived finality and any future litigation appetite.
Background
The article describes a class-action settlement tied to allegations that GoodRx shared users’ health information with analytics and advertising companies, including Criteo.
Ticker impact
GoodRx agreed to a $32M class-action settlement over alleged sharing of users’ health data with analytics and advertising partners, including Criteo.
Likely limited immediate upside, with any move driven by how investors price legal risk and settlement finality rather than fundamentals.
The article is a settlement announcement with a defined fund size and claim process, but it does not provide guidance changes or a clear magnitude relative to earnings, so price impact is likely modest.
Market effects
Highlights ongoing regulatory and litigation risk around health-data privacy for digital health and prescription-discount platforms.
Primarily US-focused consumer class-action process; limited direct cross-market spillover.
Moderate, as privacy litigation frameworks and ad-tech data-sharing scrutiny are globally relevant.
Counterpoint
Because the settlement excludes Meta and Google and does not indicate an admission of wrongdoing, the market may treat it as a contained cost rather than a signal of broader systemic liability.
Key entities
- companyGoodRx
Digital health care company that agreed to a $32 million class-action settlement over alleged health-data sharing.
- companyCriteo
Advertising/analytics company named in the lawsuit; both parties denied allegations but settled with plaintiffs.
- companyMeta
Named as a defendant in the lawsuit, but excluded from the settlement described in the article.
- companyGoogle
Named as a defendant in the lawsuit, but excluded from the settlement described in the article.


